INFECTIOUS DISEASE

With a focus on understanding globally important infectious diseases, Colorado State University is home to world-renowned scientists and leaders researching vector-borne diseases, drug-resistant bacterium, and numerous viral diseases. The Infectious Disease Research Center (IDRC) provides a high quality research environment for developing new scientific discoveries, vaccines, methods of diagnosis, and therapeutic agents for infectious agents, including BSL-3 laboratories and BioMARC’s cGMP manufacturing infrastructure and expertise.

Our capabilities are built on a foundation of faculty-based research programs spanning decades.  Much of our current research includes COVID-19, Tuberculosis, HIV, Dengue, Zika, Ebola, Malaria, Lyme Disease and other pathogens of interest from both an animal and human health perspective.  Our mission, quite simply stated, is to defeat global health threats.

To that end, we have curated a list of technologies that we believe may be of value to those involved in mitigating the current COVID-19 pandemic in addition to numerous other infectious diseases that continually devastate populations worldwide.

COVID Innovation Note: Colorado State University has committed to technology licensing principles intended to facilitate and maximize access to university innovations that can address the COVID-19 pandemic.  As part of the worldwide University technology transfer network, CSU is endorsing the licensing principles found at the Association of University Technology Managers (AUTM) website (COVID-19 Licensing Guidelines).

Infectious Disease-Related Technologies

Direct Immune-microbiome Quantitation

Direct Immune-microbiome Quantitation

Novel Inhibition of HIV-1 Infection

Novel Inhibition of HIV-1 Infection

Inhibitors of Nontuberculous Mycobacteria Biofilms

Inhibitors of Nontuberculous Mycobacteria Biofilms

COVID-19 Tracking

COVID-19 Tracking

SolaVAX™: Novel Production of Vaccines Comprising Inactivated Viral Particles

SolaVAX™: Novel Production of Vaccines Comprising Inactivated Viral Particles

Biomarker for Low-Risk NTM Infection

Biomarker for Low-Risk NTM Infection

Isolation and Detection Methods of Viruses from Drinking Water

Isolation and Detection Methods of Viruses from Drinking Water

Capacitive Immunosensor for Point-of-Care Diagnostics

Capacitive Immunosensor for Point-of-Care Diagnostics

Synthetic Biology Based Diagnostic Assay

Synthetic Biology Based Diagnostic Assay

Radioimmunometric Assay to measure Anti-SARS-COV2 Antibodies in Serum

Radioimmunometric Assay to measure Anti-SARS-COV2 Antibodies in Serum

Monoclonal Antibodies Targeting SARS-CoV-2 Nucleocapsid Protein

Monoclonal Antibodies Targeting SARS-CoV-2 Nucleocapsid Protein

Differentiation of Early Lyme Disease from Southern Tick-Associated Rash Illness (STARI)

Differentiation of Early Lyme Disease from Southern Tick-Associated Rash Illness (STARI)

A Facial Mask Capable of Detecting COVID-19 via Colorimetric Indication

A Facial Mask Capable of Detecting COVID-19 via Colorimetric Indication

Paper-Based Assay for Antimicrobial Resistant Bacteria Detection

Paper-Based Assay for Antimicrobial Resistant Bacteria Detection

Early Lyme Disease Detection

Early Lyme Disease Detection

Ventilator System: Optimized Functionality and Utilization of Non-Medical Supply Chains

Ventilator System: Optimized Functionality and Utilization of Non-Medical Supply Chains

A Hygiene Wipe Capable of Detecting COVID-19 via Colorimetric Indication

A Hygiene Wipe Capable of Detecting COVID-19 via Colorimetric Indication

Plasmid to Produce Recombinant SARS-CoV-2 Nucleocapsid Protein

Plasmid to Produce Recombinant SARS-CoV-2 Nucleocapsid Protein

Engineered Lactobacilli for Use in Oral Vaccines Against Human Coronaviruses (Covid-19)

Engineered Lactobacilli for Use in Oral Vaccines Against Human Coronaviruses (Covid-19)

Inactivation of Viral Particles and Other Pathogens Using Bulk Sterilization

Inactivation of Viral Particles and Other Pathogens Using Bulk Sterilization

Nasal Immunotherapy Spray for Prevention of Viral Respiratory Tract Infections

Nasal Immunotherapy Spray for Prevention of Viral Respiratory Tract Infections

Delivery System for Therapeutic Nucleic Acids and Vaccines

Delivery System for Therapeutic Nucleic Acids and Vaccines

Cellular Therapy for Treatment of Virally-Induced ARDS

Cellular Therapy for Treatment of Virally-Induced ARDS

Anti-infective Antibacterial Compounds against Mycobacterium tuberculosis and other Mycobacterium Species

Anti-infective Antibacterial Compounds against Mycobacterium tuberculosis and other Mycobacterium Species

Nuclease Protection ELISA Assay for Diagnosis of Infectious Disease

Nuclease Protection ELISA Assay for Diagnosis of Infectious Disease

Use of Peptide-Based Inhibitors for Treating Pathogenic Bacterial Infection and Granulomatous Disease

Use of Peptide-Based Inhibitors for Treating Pathogenic Bacterial Infection and Granulomatous Disease

Indole-based Therapeutics for Patients with Pulmonary NTM Infection

Indole-based Therapeutics for Patients with Pulmonary NTM Infection

In vitro Detection of Prions in Blood

In vitro Detection of Prions in Blood

Methods for Evaluating the in vitro-in vivo Activity Relationship of Antibacterial Compounds

Methods for Evaluating the in vitro-in vivo Activity Relationship of Antibacterial Compounds

Sindbis Virus Replicons and Plasmids

Sindbis Virus Replicons and Plasmids

Smart Bandage for Bacterial Infection Diagnosis and Therapeutics

Smart Bandage for Bacterial Infection Diagnosis and Therapeutics

Zika Virus Plasmids

Zika Virus Plasmids

Novel Antibacterial Surfaces

Novel Antibacterial Surfaces

Enzyme-Linked Immunoassay to Detect Felis catus Gammaherpesvirus 1

Enzyme-Linked Immunoassay to Detect Felis catus Gammaherpesvirus 1

Production of Purified Mycobacterial Extracellular Vesicles

Production of Purified Mycobacterial Extracellular Vesicles

Ivermectin-Treated Bird Feed to Control West Nile Virus Transmission to Humans

Ivermectin-Treated Bird Feed to Control West Nile Virus Transmission to Humans

Utilization of Exosomes as a Source of Mycobacterium Tuberculosis Diagnostic Biomarkers

Utilization of Exosomes as a Source of Mycobacterium Tuberculosis Diagnostic Biomarkers

Novel Broad-Spectrum Flavivirus Inhibitors

Novel Broad-Spectrum Flavivirus Inhibitors

Diagnostic for Paratuberculosis Infection: Johne’s and Crohn’s Disease

Diagnostic for Paratuberculosis Infection: Johne’s and Crohn’s Disease

Infectious Disease-Related #CSUStartup

Colorado State University
The SOURCE | Infectious Disease Spotlight Stories